🇺🇸 FDA
Pipeline program

OXALIPLATIN, CAPECITABINE

Approved small_molecule active

Quick answer

OXALIPLATIN, CAPECITABINE for Locally advanced or metastatic gastro-intestinal carcinoma is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Locally advanced or metastatic gastro-intestinal carcinoma
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials